Skip to content
🧬 Beyond the Shelf: How Synthetic Biology Startups Are Disrupting Traditional CPG Supply ChainsÂ
The Day Biotech Derailed a Household Brand’s Go-to-Market Plan In late 2024, a global CPG giant delayed its launch of a plant-based skincare line in Europe. The reason? A small synthetic biology startup had already partnered with two regional retailers, offering lab-grown ingredients with superior efficacy and sustainability claims—at 20% lower cost. What shocked the …
Hi, This is Emma. Let’s get the conversation started!